GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » Ending Cash Position

Jubilant Pharmova (BOM:530019) Ending Cash Position : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Jubilant Pharmova Ending Cash Position?

Jubilant Pharmova's Ending Cash Position for the quarter that ended in Mar. 2024 was ₹0 Mil.

Jubilant Pharmova's annual Ending Cash Position increased from Mar. 2022 (₹9,838 Mil) to Mar. 2023 (₹10,139 Mil) but then declined from Mar. 2023 (₹10,139 Mil) to Mar. 2024 (₹9,564 Mil).

Jubilant Pharmova Ending Cash Position Historical Data

The historical data trend for Jubilant Pharmova's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jubilant Pharmova Ending Cash Position Chart

Jubilant Pharmova Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12,308.14 5,019.57 9,838.19 10,139.00 9,564.00

Jubilant Pharmova Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Jubilant Pharmova Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Jubilant Pharmova's Ending Cash Position for the fiscal year that ended in Mar. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=10139+-575
=9,564

Jubilant Pharmova's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0

Jubilant Pharmova Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Jubilant Pharmova's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Jubilant Pharmova (BOM:530019) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jubilant Pharmova Ltd (BOM:530019) » Definitions » Ending Cash Position
Comparable Companies
BOM:531599 BOM:532872 BOM:543322 BOM:524742 BOM:524558 BOM:532482 NSE:STAR BOM:524348 BOM:500126 BOM:543748 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
JUBLPHARMA:India
Address
1A, Sector 16A, Noida, UP, IND, 201 301
Website
https://www.jubilantpharmova.com
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.

Jubilant Pharmova (BOM:530019) Headlines

No Headlines